Cargando…
miR-671-5p Blocks The Progression Of Human Esophageal Squamous Cell Carcinoma By Suppressing FGFR2
Esophageal cancer is the eighth most common malignant tumor worldwide, of which esophageal squamous cell carcinoma (ESCC) is the dominant histological subtype. A drug shortage for ESCC therapy triggered us to explore the roles of fibroblast growth factor receptor 2 (FGFR2) and its upstream regulator...
Autores principales: | Li, Xiaoyan, Nie, Changjun, Tian, Baoqing, Tan, Xuan, Han, Wei, Wang, Jiakang, Jin, Yuan, Li, Yadan, Guan, Xinyuan, Hong, An, Chen, Xiaojia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743296/ https://www.ncbi.nlm.nih.gov/pubmed/31523191 http://dx.doi.org/10.7150/ijbs.32429 |
Ejemplares similares
-
CACNA2D3 Enhances the Chemosensitivity of Esophageal Squamous Cell Carcinoma to Cisplatin via Inducing Ca(2+)-Mediated Apoptosis and Suppressing PI3K/Akt Pathways
por: Nie, Changjun, et al.
Publicado: (2019) -
Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma
por: Tian, Baoqing, et al.
Publicado: (2017) -
Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway
por: Jin, Yuan, et al.
Publicado: (2021) -
MiR‐671‐5p sponging activity of circMMP1 promotes esophageal squamous cancer progression
por: Li, Rong, et al.
Publicado: (2023) -
Blocking FGFR4 exerts distinct anti‐tumorigenic effects in esophageal squamous cell carcinoma
por: Xin, Zhongwei, et al.
Publicado: (2018)